Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

NANot yet recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

April 30, 2028

Conditions
Congenital Heart DiseaseCongenital Heart Disease (CHD)
Interventions
DEVICE

Ductus Arteriosus Stent

The eligible subjects will proceed to implantation of the Lifeline Ductus Arteriosus Stent to maintain patency of the PDA.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Starlight Cardiovascular Inc

INDUSTRY

NCT07114718 - Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study | Biotech Hunter | Biotech Hunter